Makiko Nanishi1, Michimasa Fujiogi1, Robert J Freishtat2,3, Claire E Hoptay4, Cindy S Bauer5, Michelle D Stevenson6, Carlos A Camargo1, Kohei Hasegawa1. 1. Department of Emergency Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA. 2. Department of Genomics and Precision Medicine, George Washington University, Washington, District of Columbia, USA. 3. Division of Emergency Medicine, Children's National Hospital, Washington, District of Columbia, USA. 4. Children's Research Institute, Children's National Hospital, Washington, District of Columbia, USA. 5. Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Arizona, USA. 6. Department of Pediatrics, Emergency Medicine, Norton Children's Hospital, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Abstract
BACKGROUND: Infants hospitalized for bronchiolitis (severe bronchiolitis) are at high risk for developing childhood asthma. However, the pathobiological link between these conditions remains unclear. We examined the longitudinal relationship of periostin (an extracellular matrix protein upregulated in response to type 2 inflammation) during bronchiolitis with the subsequent development of asthma. METHODS: In a 17-center prospective cohort study of infants (aged <1 year) with severe bronchiolitis, we measured the serum periostin level at hospitalization and grouped infants into 3 groups: low, intermediate, and high levels. We examined their association with asthma development by age 6 years and investigated effect modification by allergic predisposition (eg, infant's IgE sensitization). RESULTS: The analytic cohort consists of 847 infants with severe bronchiolitis (median age, 3 months). Overall, 28% developed asthma by age 6 years. In the multivariable model adjusting for nine patient-level factors, compared to the low periostin group, the asthma risk was significantly higher among infants in the intermediate group (23% vs. 32%, OR 1.68, 95%CI 1.12-2.51, p = .01) and non-significantly higher in the high-level group (28%, OR 1.29, 95%CI 0.86-1.95, p = .22). In the stratified analysis, infants with IgE sensitization had a significantly higher risk for developing asthma (intermediate group, OR 4.76, 95%CI 1.70-13.3, p = .002; high group, OR 3.19, 95%CI 1.08-9.36, p = .04). By contrast, infants without IgE sensitization did not have a significantly higher risk (p > .15). CONCLUSIONS: In infants with severe bronchiolitis, serum periostin level at bronchiolitis hospitalization was associated with asthma risk by age 6 years, particularly among infants with an allergic predisposition.
BACKGROUND: Infants hospitalized for bronchiolitis (severe bronchiolitis) are at high risk for developing childhood asthma. However, the pathobiological link between these conditions remains unclear. We examined the longitudinal relationship of periostin (an extracellular matrix protein upregulated in response to type 2 inflammation) during bronchiolitis with the subsequent development of asthma. METHODS: In a 17-center prospective cohort study of infants (aged <1 year) with severe bronchiolitis, we measured the serum periostin level at hospitalization and grouped infants into 3 groups: low, intermediate, and high levels. We examined their association with asthma development by age 6 years and investigated effect modification by allergic predisposition (eg, infant's IgE sensitization). RESULTS: The analytic cohort consists of 847 infants with severe bronchiolitis (median age, 3 months). Overall, 28% developed asthma by age 6 years. In the multivariable model adjusting for nine patient-level factors, compared to the low periostin group, the asthma risk was significantly higher among infants in the intermediate group (23% vs. 32%, OR 1.68, 95%CI 1.12-2.51, p = .01) and non-significantly higher in the high-level group (28%, OR 1.29, 95%CI 0.86-1.95, p = .22). In the stratified analysis, infants with IgE sensitization had a significantly higher risk for developing asthma (intermediate group, OR 4.76, 95%CI 1.70-13.3, p = .002; high group, OR 3.19, 95%CI 1.08-9.36, p = .04). By contrast, infants without IgE sensitization did not have a significantly higher risk (p > .15). CONCLUSIONS: In infants with severe bronchiolitis, serum periostin level at bronchiolitis hospitalization was associated with asthma risk by age 6 years, particularly among infants with an allergic predisposition.
Authors: Philip E Silkoff; Michel Laviolette; Dave Singh; J Mark FitzGerald; Steven Kelsen; Vibeke Backer; Celeste M Porsbjerg; Pierre-Olivier Girodet; Patrick Berger; Joel N Kline; Geoffrey Chupp; Vedrana S Susulic; Elliot S Barnathan; Frédéric Baribaud; Matthew J Loza Journal: J Allergy Clin Immunol Date: 2017-01-13 Impact factor: 10.793
Authors: R Caswell-Smith; A Hosking; T Cripps; C Holweg; J Matthews; M Holliday; C Maillot; J Fingleton; M Weatherall; I Braithwaite; R Beasley Journal: Clin Exp Allergy Date: 2016-06-28 Impact factor: 5.018
Authors: Kohei Hasegawa; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; David M Henke; Joseph F Petrosino; Pedro A Piedra; Chad A Shaw; Ashley F Sullivan; Carlos A Camargo Journal: Eur Respir J Date: 2016-10-06 Impact factor: 16.671
Authors: Kohei Hasegawa; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Robert J Freishtat; Stephen J Teach; Pedro A Piedra; Carlos A Camargo Journal: J Allergy Clin Immunol Date: 2016-11-12 Impact factor: 10.793
Authors: A James; C Janson; A Malinovschi; C Holweg; K Alving; J Ono; S Ohta; A Ek; R Middelveld; B Dahlén; B Forsberg; K Izuhara; S-E Dahlén Journal: Allergy Date: 2017-05-22 Impact factor: 13.146
Authors: Yoshihiko Raita; Marcos Pérez-Losada; Robert J Freishtat; Brennan Harmon; Jonathan M Mansbach; Pedro A Piedra; Zhaozhong Zhu; Carlos A Camargo; Kohei Hasegawa Journal: Nat Commun Date: 2021-06-14 Impact factor: 17.694